Immunohistochemistry (IHC) reagents and kits find diverse applications in medical research, diagnostics, and pathology. These essential tools aid in visualizing specific proteins or antigens in tissue samples, allowing precise disease diagnosis and understanding of cellular functions. IHC kits contain antibodies and other components required for staining tissue sections, providing researchers with accurate and reliable results. Their features include high specificity and sensitivity, enabling the identification of target proteins, making IHC reagents and kits invaluable for advancing medical research and enhancing disease diagnosis and treatment.
According to Data Bridge Market Research, the Global Immunohistochemistry (IHC) Reagents and Kits Market accounted for USD 2.3 billion in 2021 and would expect to USD 4.18 billion by 2029. The market is expected to grow with a CAGR of 7.75% in the forecast period of 2022 to 2029.
“Rising incidence of chronic diseases boosts the market’s growth”
The immunohistochemistry (IHC) reagents and kits market experiences growth due to the rising incidence of chronic diseases. IHC plays a crucial role in diagnosing and understanding various diseases, including cancer and autoimmune disorders. With an increasing number of patients being diagnosed with chronic illnesses, the demand for IHC reagents and kits for accurate and reliable disease detection and research purposes also rises. This trend is expected to drive the market's expansion as healthcare providers and researchers rely on IHC for enhanced disease analysis and treatment planning.
What restraints the growth of the global immunohistochemistry (IHC) reagents and kits market?
“High cost associated with these products restraints the market’s growth”
The growth of the immunohistochemistry (IHC) reagents and kits market is restrained by the high cost associated with these products. IHC reagents and kits require specialized technology and materials for accurate and reliable results, making them expensive for healthcare facilities and research laboratories. The high cost of acquisition and maintenance can deter some potential buyers from adopting IHC solutions. Additionally, budget constraints in certain healthcare settings may limit the widespread adoption of IHC technology, impacting the market's growth.
Segmentation: Global Immunohistochemistry (IHC) Reagents and Kits Market
The global immunohistochemistry (IHC) reagents and kits market is segmented on the basis of product, application, and end-user.
- On the basis of product, the immunohistochemistry (IHC) reagents and kits market is segmented into antibodies, equipment, slide staining systems, tissue microarrays, tissue processing systems, slide scanners, reagents, chromogenic substrates, historical stains, organic solvent, stabilizers, kits, others.
- On the basis of application, the immunohistochemistry (IHC) reagents and kits market is divided into diagnostics, cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes mellitus, drug testing, and nephrological diseases.
- On the basis of end user, the immunohistochemistry (IHC) reagents and kits market is segmented into hospitals, diagnostic laboratories, research institutes, and others.
Regional Insights: North America dominates the Global Immunohistochemistry (IHC) Reagents and Kits Market
North America dominates the immunohistochemistry (IHC) reagents and kits market due to growing demand for improved healthcare infrastructure and the need for enhanced medical services has led to increased investments in the healthcare sector. As the pressure to provide better healthcare services rises, governments and private entities are channelling more resources into healthcare infrastructure, facilities, and technologies to meet the rising healthcare demands.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the large population in emerging economies like China, India, and Japan. Additionally, the rising prevalence of chronic diseases, increasing demand for quality medical care, and the growth in healthcare spending are expected to
To know more about the study visit, https://www.databridgemarketresearch.com/ar/reports/global-immunohistochemistry-ihc-reagents-and-kits-market
Recent Developments
- In March 2020, Visiopharm and Agilent Technologies Inc., both biotechnology companies, have joined forces in a collaborative effort to promote their histology tests for cancer patient testing and pathology. Additionally, they aim to develop an improved solution for the cancer diagnosis market.
- In June 2019, PHC Holding acquired Thermo Fisher Scientific, Inc.'s Anatomical Pathology division, which specializes in selling IHC products.
- In August 2019, Roche launched the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody, the first and only in vitro diagnostic ROS1 IHC assay.
The Prominent Key Players Operating in the Global Immunohistochemistry (IHC) Reagents and Kits Market Include:
- F. Hoffman-La Roche AG (Switzerland)
- Danaher (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Merck KGaA (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Bio-Techne Corporation (U.S.)
- Abcam plc (U.K.)
- BD (U.S.)
- PerkinElmer, Inc. (U.S.)
- Takara Bio, Inc. (Japan)
- Thermo Fisher Scientific, Inc. (U.S.)
- PHC Holdings Corporation (Japan)
- Cell Signaling Technology, Inc. (U.S.)
- Bio SB, Inc. (U.S.)
- Miltenyi Biotec (Germany)
- CANDOR Bioscience GmbH (Germany)
- Sakura Finetek Japan Co. Ltd. (Japan)
- Eagle Biosciences, Inc. (U.S.)
- Biocare Medical, LLC (U.S.)
- Elabscience, Inc. (China)
Above are the key players covered in the report, to know about more and exhaustive list of global immunohistochemistry (IHC) reagents and kits market companies contact, https://www.databridgemarketresearch.com/ar/contact
Research Methodology: Global Immunohistochemistry (IHC) Reagents and Kits Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
